Oliver Dorigo

Cancer Prevention Institute of California

ORCID: 0000-0002-1976-5201

Also affiliated with Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Revealing the human mucinome”.

Revealing the human mucinome

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428510

N/A

0DataRank · unranked

12 citations

Nicholas M. Riley, D. Judy Shon, Kayvon Pedram, Venkatesh Krishnan, Oliver Dorigo +2 more

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

The Lancet Oncology(2022)10.1016/s1470-2045(22)00139-5

N/A

0DataRank · unranked

142 citations

Antonio González-Martı́n, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean‐Emmanuel Kurtz +73 more

Revealing the human mucinome

Nature Communications(2022)10.1038/s41467-022-31062-4

N/A

0DataRank · unranked

105 citations

Nicholas M. Riley, D. Judy Shon, Kayvon Pedram, Venkatesh Krishnan, Oliver Dorigo +2 more

Data from Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma

(2023)10.1158/1078-0432.c.6518930.v1

N/A

0DataRank · unranked

0 citations

Gottfried E. Konecny, Mirela Fekete, Kuang-Yui Michael Chen, Amer Karam, David J. Mulholland +5 more

Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer

Gynecologic Oncology Reports(2025)10.1016/j.gore.2025.101738

N/A

0DataRank · unranked

3 citations

Filippos Vingopoulos, Isabel Beshar, Sahana Somasegar, EJ Adams, Simone Sasse +7 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042

N/A

0DataRank · unranked

2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more